|Day Low/High||3.70 / 3.95|
|52 Wk Low/High||3.60 / 9.65|
Overall it was a good year for this somewhat off the wall screen that I developed several years ago as a way to find seemingly cheap companies.
Electro Scientific Industries leads a parade of value stocks that have performed quite nicely in a growth-oriented market.
Despite the disparity this year between growth and value, my 2017 Double Net Value Portfolio is not struggling.
My tracking portfolio is flat for the year to date, though there have been wildly divergent performances by the constituent stocks.
An eclectic mix of 20 companies made my cut of stocks trading at 1x to 2x net current asset value.
Graham screening reveals 2 names from past vintages and reason to be skeptical of retailers.
This collection of beaten-down small-caps is beating its benchmarks.
These firms would look great to the godfather of value investing.
The legendary investor beat the market for nearly a half-century.
Should we buy a stock executives and directors are busy selling?
Where it began. The rundown: • U.S. futures are lower this morning. (S&P 500 futures are down 7 and Nasdaq futures are 16 handles lower) • Europe is broadly weaker as well. . • Nikkei off 0.70%. Within the Japanese bourse, energy, financials and hea...
Where it began. The bulls will be focused on the benefit of continued low interest rates and its salutary impact on stock valuations. Question: Should market P/E trend higher based on ever easy central bank that brings a lower-than-historical level ...
Wal-Mart agrees to improve safety conditions at more than 2,800 U.S. stores and pay $190,000 in a settlement with the Labor Department.
Eli Lilly says its experimental diabetes drug dulaglutide met goals in two late-phase studies. Brittany Umar has details on that as well as a lok at the rest of the morning's top news.
The sector has a large number of safe and cheap stocks that are worth checking out.
A look at the day's most searched trends on the Web, including Tesco after the retailer announced plans to exit its U.S. grocery chain Fresh & Easy.
These two names passed my value screen, and they have underperformed so far this year.
For the foreseeable future, we will need to dig and drill to meet demand on a cost-effective efficient basis.
Rather than buy names the Oracle has owned for years, let's try and vet out the next great investments.